Personalized Evidence-based Medicine in Patients With Atrial Fibrillation

Center of Personalized Medicine, Pirogova

Status: Completed

Conditions: Adherence to Personalized EBM Anticoagulant Treatment in Patients at High Risk for Stroke

Treatments: Drug: anticoagulation treatment

Study type: Observational

Funder types: Other

Identifiers

NCT04774341

20210225

Details and patient eligibility

About

A retrospective analysis

Full description

4200 EMR of patients at high risk for stroke with 1-year follow-up will be enrolled in the current study and analyzed by clinical decision support systems (CDSS MedicBK) utilizing a core laboratory.

Enrollment: 4,200 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

EMR only if an ECG diagnosis (12-lead ECG, 24-h Holter, or other electrocardiographic documentation) confirming AF was made in patients at high risk for stroke by CHA2DS2-VASc (≥2 in men and ≥3 in women).

Exclusion criteria

No

Trial design

4,200 participants in 2 patient groups

CDSS (MedicBK) Analysis

Treatment:

Drug: anticoagulation treatment

Core Laboratory Analysis

Treatment:

Drug: anticoagulation treatment